photo of Rosalind Watts, PhD

Rosalind Watts, PhD


As former Clinical Lead of the Psilocybin for Depression trial at Imperial College London, Rosalind Watts, PhD, led a clinical team which facilitated over a hundred psilocybin treatment sessions. She is now exploring the potential of DMT as a treatment for depression as a consultant therapist in a clinical trial by Small Pharma in the UK. Dr Watts published qualitative research suggesting that the central psychological mechanism of psychedelic-assisted therapy could be ‘connectedness to self, others and world.’ She published a therapy protocol to assist the process of connecting deeply to the body, emotions, and insights during psychedelic sessions, and also developed a community-based integration program designed to help people maintain connectedness to self, others, and the natural world for 12 months following treatment. In order to quantify the impact of psychedelic-assisted therapy, Dr Watts and colleagues have constructed and validated a psychometric tool, the Watts Connectedness Scale. She also consults for the Synthesis Institute’s Psychedelic Practitioner Training program, and the Usona Institute, a not-for-profit psilocybin manufacturer and research organization.

Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.

Events featuring Rosalind Watts, PhD
Events featuring Rosalind Watts, PhD